BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Plus Therapeutics Announces Reverse Stock Split

  March 31, 2026

   · 

  5 min read
• Press Releases

  Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results

  March 31, 2026

   · 

  10 min read
• Press Releases

  Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

  March 31, 2026

   · 

  5 min read
• Press Releases

  ImmunityBio Strengthens Balance Sheet with $100 Million of Financing Transactions Including $75 Million of Non-Dilutive Financing to Support Global Expansion and Advancement of Broader Immunotherapy Pipeline

  March 31, 2026

   · 

  7 min read
• Press Releases

  CellCentric Initiates DOMMINO-1, a Pivotal Phase 2 Clinical Trial of Inobrodib in Combination with Pomalidomide and Dexamethasone (InoPd) in Relapsed or Refractory Multiple Myeloma

  March 31, 2026

   · 

  4 min read
• Press Releases

  Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

  March 31, 2026

   · 

  10 min read
• Press Releases

  Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting

  March 31, 2026

   · 

  1 min read
• Press Releases

  Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress

  March 31, 2026

   · 

  15 min read
• Press Releases

  Catheter Precision Reports 2025 Results and Updates on Strategic Expansion

  March 31, 2026

   · 

  11 min read
• Press Releases

  Adcytherix Doses First Patient in Phase 1 Trial of ADCX-020 and Strengthens Leadership to Support Next Phase of Growth

  March 31, 2026

   · 

  4 min read